DIVIS: Integrated and Customizable Pipeline for Cancer Genome Sequencing Analysis and Interpretation

Next-generation sequencing (NGS) has drastically enhanced human cancer research, but diverse sequencing strategies, complicated open-source software, and the identification of massive numbers of mutations have limited the clinical application of NGS. Here, we first presented GPyFlow, a lightweight t...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology Vol. 11; p. 672597
Main Authors: He, Xiaoyu, Zhang, Yu, Yuan, Danyang, Han, Xinyin, He, Jiayin, Duan, Xiaohong, Liu, Siyao, Wang, Xintong, Niu, Beifang
Format: Journal Article
Language:English
Published: Frontiers Media S.A 08-06-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Next-generation sequencing (NGS) has drastically enhanced human cancer research, but diverse sequencing strategies, complicated open-source software, and the identification of massive numbers of mutations have limited the clinical application of NGS. Here, we first presented GPyFlow, a lightweight tool that flexibly customizes, executes, and shares workflows. We then introduced DIVIS, a customizable pipeline based on GPyFlow that integrates read preprocessing, alignment, variant detection, and annotation of whole-genome sequencing, whole-exome sequencing, and gene-panel sequencing. By default, DIVIS screens variants from multiple callers and generates a standard variant-detection format list containing caller evidence for each sample, which is compatible with advanced analyses. Lastly, DIVIS generates a statistical report, including command lines, parameters, quality-control indicators, and mutation summary. DIVIS substantially facilitates complex cancer genome sequencing analyses by means of a single powerful and easy-to-use command. The DIVIS code is freely available at https://github.com/niu-lab/DIVIS , and the docker image can be downloaded from https://hub.docker.com/repository/docker/sunshinerain/divis .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Yongsheng Kevin Li, Hainan Medical University, China
This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology
Reviewed by: Haishan Huang, Wenzhou Medical University, China; Shuang Li, Huazhong University of Science and Technology, China
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.672597